Quarterly report pursuant to Section 13 or 15(d)

Recent Developments, Liquidity and Management???s Plans (Details Narrative)

v3.23.3
Recent Developments, Liquidity and Management’s Plans (Details Narrative)
3 Months Ended 9 Months Ended
Jun. 28, 2023
shares
Feb. 21, 2023
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
Apr. 16, 2021
$ / shares
Reverse stock split description                 the Company effected a 1-for-2 reverse stock split of the issued and outstanding Company Common Stock        
Share value new issues         $ 5,550,028              
Preferred stock dividends     $ 1,158,051         $ 1,690,180      
Derivative liability fair value   $ 3,149,800 898,100           898,100        
Stock issuance costs                 314,311        
Fair value of the warrants                 10,623,000        
Change in fair value of Derivatives Liabilities     $ 2,566,900         $ 2,251,700      
Probability of default     8.2           8.2        
Preferred Stock Dividends, Shares | shares     871,323           871,323        
Dividends preferred stock     $ 766,503           $ 766,503        
Stock Issued During Period, Value, Conversion of Units     2,347,852           4,695,704        
Fair value of the warrants                 10,623,000      
Issuance of warrants                 762,834        
Change in fair value of Warrant Liabilities     (5,356,000)         (8,166,000)      
Fair value of warrants     2,457,000           2,457,000      
Cash on hand     298,318           298,318   749,090    
Marketable securities     8,174,283           8,174,283   4,086,902    
Loss from operations                 1,636,391        
Working capital     4,040,337           4,040,337        
Stockholders' equity     15,500,682 $ 10,741,770 13,094,059 18,327,047 $ 16,118,343 $ 19,622,140 15,500,682 18,327,047 14,695,056 $ 23,647,174  
Accumulated deficit     97,085,475           97,085,475   $ 93,758,904    
Net cash provided by operating activities                 11,047,995 10,021,664      
Net loss     (4,042,994) 4,167,653 1,511,732 3,693,741 3,636,043 4,122,034 1,636,391 11,451,818      
Prepaid expenses                 697,691 (113,217)      
Decrease in trade and other payables                 639,381 (730,683)      
Fair value of the warrant liability                 10,417,700        
Share based compensation     595,576     352,417     2,341,915 581,663      
Other Operating Income (Expense) [Member]                          
Change in fair value of Derivatives Liabilities     2,566,900           2,251,700        
Fair value of common stock on valuation date     590,000           590,000        
Change in fair value of Warrant Liabilities     $ 5,356,000           $ 8,166,000        
Measurement Input, Expected Dividend Rate [Member]                          
Estimated dividend rate   10.00 10.00           10.00        
Estimated Equity volatility                 130.00%        
Fair value assumptions risk free interest rate                 5.49%        
Measurement Input, Option Volatility [Member]                          
Estimated dividend rate   120.00                      
Stock price per share     125.0           125.0        
Measurement Input, Price Volatility [Member]                          
Estimated dividend rate   190.00                      
Measurement Input, Maturity [Member]                          
Time of maturity   1 year 4 months 6 days                      
Measurement Input, Maturity [Member] | Other Operating Income (Expense) [Member]                          
Time of maturity                 9 months        
Measurement Input, Discount Rate [Member]                          
Estimated dividend rate   6.08                      
Measurement Input, Lapse Rate [Member]                          
Estimated dividend rate   15.00 15.00           15.00        
Measurement Input, Default Rate [Member]                          
Estimated dividend rate   0.05                      
Measurement Input Volume Volatility [Member]                          
Estimated traded volume volatility     120.0           120.0        
Measurement Input, Expected Dividend Payment [Member]                          
Stock price per share     0           0        
Measurement Input, Risk Free Interest Rate [Member]                          
Stock price per share     4.09           4.09        
Series F Convertible Preferred Stock [Member]                          
Conversion price | $ / shares   $ 2.255                      
Conversion of stock, description   (i) the Conversion Price then in effect and (ii) the greater of (A) 80% of the average of the three lowest closing prices of the Company’s Common Stock during the thirty trading day period immediately prior to the date the amortization payment is due or (B) a “Floor Price” of $0.22 (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) or, in any case, such lower amount as permitted, from time to time, by the Nasdaq Stock Market.             If on any day after the issuance of the shares of Series F Preferred Stock the closing price of the Common Stock has exceeded 300% of the Conversion Price per share (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) for 20 consecutive trading days and the daily dollar trading volume of the Common Stock has exceeded $3,000,000 per trading day during the same period and certain equity conditions described in the Series F Certificate of Designation are satisfied (the “Mandatory Conversion Date”), we shall deliver written notice of the Mandatory Conversion (as defined below) to all holders on the Mandatory Conversion Date and, on such Mandatory Conversion Date, we shall convert all of each holder’s shares of Series F Preferred Stock into Conversion Shares at the then effective Conversion Price (the “Mandatory Conversion”). If any of the Equity Conditions shall cease to be satisfied at any time on or after the Mandatory Conversion Date through and including the actual delivery of all of the Conversion Shares to the holders, the Mandatory Conversion shall be deemed withdrawn and void ab initio.        
Share issued price, per share | $ / shares   $ 6.765                      
Share value new issues   $ 3,000,000                      
Preferred shares dividend rate   10.00%             10.00%        
Series F Convertible Preferred Stock [Member] | Measurement Input, Expected Dividend Rate [Member]                          
Preferred shares dividend rate   15.00%                      
Series F Convertible Preferred Stock [Member] | Measurement Input, Default Rate [Member]                          
Preferred shares dividend rate                 15.00%        
Securities Purchase Agreement [Member] | Investors [Member]                          
Number of shares issued | shares   15,000                      
Number of shares issued, value   $ 1,000                      
Shares issued upon conversion | shares   6,651,885                      
Warrant exercise price | $ / shares   $ 2.255                      
Warrants to purchase common stock | shares   6,651,885                      
Warrants term   5 years                      
Warrant [Member]                          
Warrants shares | shares     986,486           986,486        
Warrants term     5 years           5 years        
Warrant [Member] | Measurement Input, Expected Dividend Rate [Member]                          
Stock price per share     0           0        
Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]                          
Stock price per share     4.66           4.66        
Warrant [Member] | Measurement Input, Expected Term [Member]                          
Warrants term     4 years 4 months 24 days           4 years 4 months 24 days        
Warrant [Member] | Measurement Input Equity Volatility [Member]                          
Stock price per share     115.0           115.0        
Common Stock [Member]                          
Warrants shares | shares     4,188,315           4,188,315        
Share value new issues         5,550,028              
Exercise price | $ / shares     $ 0.59           $ 0.59   $ 1.15    
Issuance of preferred shares | shares 73,776   4,101,909           6,450,122        
Preferred Stock Dividends, Shares | shares     871,323                    
Stockholders' equity     $ 112,441,633 110,567,664 108,378,504 108,195,909 102,293,464 102,161,218 $ 112,441,633 108,195,909 $ 108,309,436 102,064,218  
Net loss              
Common Stock [Member] | Measurement Input, Exercise Price [Member]                          
Exercise price | $ / shares   $ 1.90                      
Preferred Stock [Member]                          
Share value new issues                 14,087,111        
Derivative liability fair value     3,149,800           3,149,800        
Conversion of preferred stock     152,149           304,296        
Preferred Stock [Member] | Series F Convertible Preferred Stock [Member]                          
Share value new issues         912,889              
Stockholders' equity      
Net loss              
Former MyMD Florida Equity Holders [Member]                          
Equity percentage     77.05%           77.05%        
Akers Bio Sciences Inc [Member]                          
Equity percentage     22.95%           22.95%        
MyMD Pharmaceuticals (Florida), Inc [Member]                          
Common stock, par value | $ / shares                         $ 0.001
Exchange ratio price per shares | $ / shares                         $ 0.7718